JPMorgan Chase & Co’s Aardvark Therapeutics, Inc. Common Stock AARD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$36.2K Sell
2,677
-423
-14% -$5.72K ﹤0.01% 5195
2025
Q1
$23.3K Buy
+3,100
New +$23.3K ﹤0.01% 5244